A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
Recruiting
Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship.
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * English or Spanish speaking adults (18+ at time of enrollment) * Within 1-5 years of completing active treatment for lymphoma (includes surgery, chemotherapy, immunotherapy, radiation therapy, or other); individuals may be on maintenance treatment. Exclusion Criteria: * Active psychiatric, medical concern or cognitive comorbidity as determined by the site PI or treating clinician
About the study
The goal of this trial is to learn if a resilience intervention can lead to improvements in lymphoma survivors' quality of life.
What is being tested
- Health Education Program (other)
- SMART3RP-Lymphoma (other)
Sponsor: Massachusetts General Hospital · Participants: 254 · Started: Oct 6, 2026
Contact the study team
Official record on ClinicalTrials.gov — NCT07013435
Locations in the U.S.
| Florida | Sylvester Comprehensive Cancer Center, Miami |
| Massachusetts | Mass General Hospital, Boston |
| Utah | Huntsman Cancer Institute, Salt Lake City |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.